REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Cser-Pyrin Bt. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: CSER-PYRIN Gyogyszerkereskedelmi Bt. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Cser-Pyrin Bt. is based in Hungary, with the head office in Budapest. It operates in the Pharmacies and Drug Stores industry. The company was established on October 27, 1995. It currently has a total number of 5 (2024) employees. The latest financial highlights indicate a net sales revenue increase of 18.07% in 2023. A growth of 4.99% was recorded in its total assets. In 2023, Cser-Pyrin Bt.’s net profit margin decreased by 0.43%.

Headquarters
Garay ter 19.
Budapest; Budapest; Postal Code: 1076

Contact Details: Purchase the Cser-Pyrin Bt. report to view the information.

Website: http://www.garaygyogyszertar.t-online.hu

Basic Information
Total Employees:
Purchase the Cser-Pyrin Bt. report to view the information.
Outstanding Shares:
Purchase the Cser-Pyrin Bt. report to view the information.
Registered Capital:
Purchase the Cser-Pyrin Bt. report to view the information.
Financial Auditors:
Purchase the Cser-Pyrin Bt. report to view the information.
Incorporation Date:
October 27, 1995
Key Executives
Purchase this report to view the information.
Business Manager
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Cser-Pyrin Bt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
18.07%▲
Total operating revenue
18%▲
Operating profit (EBIT)
-16.98%▼
EBITDA
-17.16%▼
Net Profit (Loss) for the Period
-17.36%▼
Total assets
4.99%▲
Total equity
8.76%▲
Operating Profit Margin (ROS)
-0.58%▼
Net Profit Margin
-0.43%▼
Return on Equity (ROE)
-2.54%▼
Quick Ratio
0.08%▲
Cash Ratio
0.03%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo